Clinical trials An update on the impact of COVID-19 on the Fulcrum clinical trials April 8, 2020 By Diana Kim-vdMeij In the current global situation, it is also a challenge for companies like Fulcrum Therapeutics to continue clinical trials in times of the Covid-19 pandemic while protecting participants and clinical staff. Here is a brief update:Download Post navigation Previous PostPrevious Information for people with FSHD regarding Covid-19Next PostNext Latest Research News – Events of the FSHD Society in late June/early July 2020